Industry Watch
Abstract
Bionomics Acquires Melbourne-based Iliad Chemicals.
Cryptome Pharma and Xantos Biomedicine Join Forces to Validate Novel Cancer Lead.
VioQuest's New Production Facility in China.
AlphaRx Gains Access to Asian Markets Through Joint Venture with Basin Ltd.
Emcure Pharma Cooperates with Iceland's Actavis Pharma.
GSK and Japan's Eisai Pair Up to Sell Paritec in India.
KV Pharma Invests $11.3 Million in Strides Arcolab.
Lupin in Marketing Pact with Henry Schein.
Sumitomo Pharma and Protez Pharma Announce Licensing Agreement on Breakthrough Antibiotic.
Neuren Pharma — World Leader in Developing Treatment for Neurological Disorders.
Singapore's A-bio Collaborates with Novo Nordisk.
From Poisons to Pills.
AbGenomics Licenses Antibody to Boehringer Ingelheim.
Sino Cell and Taiwan Genome Sciences Team Up in Predictive Genetic Testing for the Taiwan Market.
Agilent Technologies Sells US$4 million in Equipment to CDC.
- Bionomics
- Melbourne-based
- lliad Chemicals
- Cryptome Pharma
- Xantos Biomedicine
- Validate Novel Cancer Lead
- VioQuest
- China
- AlphaRx
- Basin Ltd
- Emcure Pharma
- Actavis Pharma
- GSK
- Japan's Eisai
- Paritec
- KV Pharma
- Strides Arcolab
- Lupin
- Henry Schein
- Sumitomo Pharma
- Protez Pharma
- Breakthrough Antibiotic
- Neuren Pharma
- Neurological Disorder
- Singapore's A-bio
- Novo Nordisk
- Therapeutic Drug
- Toxin
- Venoms
- Poison
- Peptides
- AbGenomics
- Antibody
- Sino Cell
- Taiwan Genome Sciences
- Predictive Genetic Testing Boehringer Ingelheim
